Apogee Therapeutics

Last updated: April 19, 2024

CEO Michael Henderson

Country: USA | Funding: $652M (+)

Website: http://www.apogeetherapeutics.com/

Apogee Therapeutics operates pipeline candidates designed to treat inflammatory and immunological disorders.